Article Details
Retrieved on: 2018-02-01 12:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Moderna Therapeutics, a clinical-stage biotechnology firm that develops messenger RNA (mRNA) therapeutics and vaccines, has secured $500 million in a round participated by Singapore-based EDBI and <b>Sequoia Capital</b> China, it announced in a release. New investors include a wholly-owned ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here